BioCentury | Mar 9, 2021
Product Development

New modality deep dive; plus Sharpless speaks & Five Prime scores: a BioCentury podcast

...more information, please contact Eric Pierce and Josh Berlin at conferences@biocentury.com. Jeff Cranmer Amgen Inc. Five Prime Therapeutics Inc. National Cancer Institute U.S...
BioCentury | Mar 5, 2021
Tools & Techniques

Flexible platform: how NCI’s Sharpless thinks COVID variants could boost personalized therapies

...since returned to his role leading NIH’s National Cancer Institute...
...drug discovery in other therapeutic areas. Karen Tkach Tuzman National Cancer Institute U.S...
BioCentury | Jan 30, 2021
Product Development

How NCI is becoming COVID-19 serology’s unlikely hero

...for quickly standing up a similar resource at the start of the next pandemic.Since NIH’s National Cancer Institute...
...a lot of work ongoing to correlate their results with bona fide neutralization assays. Karen Tkach Tuzman National Cancer Institute covid-19 covid19 cov19dx serology serological...
BioCentury | Jan 14, 2021
Regulation

After pushing FDA out of and back into COVID-19 LDT review, HHS turns to outsourcing

...agency could not complete a review in time, it would then be conducted by NIH’s National Cancer Institute...
BioCentury | Dec 22, 2020
Politics, Policy & Law

Budget bill extends pediatric priority review vouchers, boosts NIH, FDA

...bringing the total for FY21 to $3.1 billion. It also includes $6.6 billion for the National Cancer Institute...
BioCentury | Nov 17, 2020
Regulation

Another U-turn for COVID-19 testing regulation as HHS requires FDA to re-prioritize LDT review

...if the agency cannot complete a review in time, it will be conducted by NIH’s National Cancer Institute...
BioCentury | Oct 9, 2020
Product Development

COVID-19 Quick Takes: Moderna won’t challenge vaccine IP, wins contract for mobile GMP manufacturing

...the University of Oxford, and Sanofi (Euronext:SAN; NASDAQ:SNY) and GlaxoSmithKline plc (LSE:GSK; NYSE:GSK). NCI’s SeroNet initiativeThe National Cancer Institute...
...Staff Veklury, remdesivir (GS-5734) Ad26.COV2.S (JNJ-78436735) Moderna Inc. U.S. Defense Advanced Research Projects Agency Gilead Sciences Inc. The European Commission Johnson & Johnson National Cancer Institute Emergent...
BioCentury | Oct 6, 2020
Product Development

Reversing the impact of COVID-19 on oncology clinical trials: Guest Commentary

...one public health crisis into many others,” National Cancer Institute...
BioCentury | Sep 17, 2020
Product Development

Data Bytes: NIH awards seven contracts for pandemic digital health tools

...companies and one academic institution to develop digital health solutions that address the COVID-19 pandemic. The National Cancer Institute...
...not only in the pandemic but beyond (see “Rules of the Road for Digital Health”). Danielle Golovin National Cancer Institute Evidation...
BioCentury | Aug 27, 2020
Product Development

Cancer Research UK, NCI partner for $550M Grand Cancer Challenges initiative

...By stephen hansen, associate editor The National Cancer Institute has joined forces with Cancer Research UK to fund...
...microbiome in cancer progression, or mapping out 3D models of different tumor types. Stephen Hansen Cancer Research UK National Cancer Institute CRUK NCI grand...
Items per page:
1 - 10 of 1390
BioCentury | Mar 9, 2021
Product Development

New modality deep dive; plus Sharpless speaks & Five Prime scores: a BioCentury podcast

...more information, please contact Eric Pierce and Josh Berlin at conferences@biocentury.com. Jeff Cranmer Amgen Inc. Five Prime Therapeutics Inc. National Cancer Institute U.S...
BioCentury | Mar 5, 2021
Tools & Techniques

Flexible platform: how NCI’s Sharpless thinks COVID variants could boost personalized therapies

...since returned to his role leading NIH’s National Cancer Institute...
...drug discovery in other therapeutic areas. Karen Tkach Tuzman National Cancer Institute U.S...
BioCentury | Jan 30, 2021
Product Development

How NCI is becoming COVID-19 serology’s unlikely hero

...for quickly standing up a similar resource at the start of the next pandemic.Since NIH’s National Cancer Institute...
...a lot of work ongoing to correlate their results with bona fide neutralization assays. Karen Tkach Tuzman National Cancer Institute covid-19 covid19 cov19dx serology serological...
BioCentury | Jan 14, 2021
Regulation

After pushing FDA out of and back into COVID-19 LDT review, HHS turns to outsourcing

...agency could not complete a review in time, it would then be conducted by NIH’s National Cancer Institute...
BioCentury | Dec 22, 2020
Politics, Policy & Law

Budget bill extends pediatric priority review vouchers, boosts NIH, FDA

...bringing the total for FY21 to $3.1 billion. It also includes $6.6 billion for the National Cancer Institute...
BioCentury | Nov 17, 2020
Regulation

Another U-turn for COVID-19 testing regulation as HHS requires FDA to re-prioritize LDT review

...if the agency cannot complete a review in time, it will be conducted by NIH’s National Cancer Institute...
BioCentury | Oct 9, 2020
Product Development

COVID-19 Quick Takes: Moderna won’t challenge vaccine IP, wins contract for mobile GMP manufacturing

...the University of Oxford, and Sanofi (Euronext:SAN; NASDAQ:SNY) and GlaxoSmithKline plc (LSE:GSK; NYSE:GSK). NCI’s SeroNet initiativeThe National Cancer Institute...
...Staff Veklury, remdesivir (GS-5734) Ad26.COV2.S (JNJ-78436735) Moderna Inc. U.S. Defense Advanced Research Projects Agency Gilead Sciences Inc. The European Commission Johnson & Johnson National Cancer Institute Emergent...
BioCentury | Oct 6, 2020
Product Development

Reversing the impact of COVID-19 on oncology clinical trials: Guest Commentary

...one public health crisis into many others,” National Cancer Institute...
BioCentury | Sep 17, 2020
Product Development

Data Bytes: NIH awards seven contracts for pandemic digital health tools

...companies and one academic institution to develop digital health solutions that address the COVID-19 pandemic. The National Cancer Institute...
...not only in the pandemic but beyond (see “Rules of the Road for Digital Health”). Danielle Golovin National Cancer Institute Evidation...
BioCentury | Aug 27, 2020
Product Development

Cancer Research UK, NCI partner for $550M Grand Cancer Challenges initiative

...By stephen hansen, associate editor The National Cancer Institute has joined forces with Cancer Research UK to fund...
...microbiome in cancer progression, or mapping out 3D models of different tumor types. Stephen Hansen Cancer Research UK National Cancer Institute CRUK NCI grand...
Items per page:
1 - 10 of 1390